Ms. Melanie Brensinger is a Founder and Managing Partner of Anagenesis Capital Partners. She is a member of the Investment Committee and is responsible for the general management of the firm as well as originating, executing, and managing investments.  Ms. Brensinger serves on the Boards of various Anagenesis’ portfolio companies. In addition, she is a Board member of the SBIA Board of Governors, Advisory Board member for the Kayo Credit Series and on the Board of The PIT Foundation.

Ms. Brensinger has over 23 years of experience originating, underwriting, and managing senior debt, junior debt and equity investments in the middle market. Prior to founding Anagenesis in 2015, Ms. Brensinger was a healthcare focused investment professional as a Managing Director and senior originator at GE Capital, Healthcare Financial Services.  She was responsible for originating and underwriting financings for private equity led healthcare investments. During her nine years at GE, Ms. Brensinger originated over 550+ healthcare investments and committed to 48+ healthcare investments and many other participant transactions aggregating over $2 billion in deployed capital. Prior to joining GE Capital, Ms. Brensinger was a Director in the Private Equity Sponsor Coverage Team at Scotia Capital, where she originated and underwrote numerous domestic and international leveraged buyouts across various industries.

In 2006, Ms. Brensinger established The PIT Foundation, a 501c3 foundation, to provide educational resources to children in Kenya. In 2009, she was nominated by her peers and selected to receive the Gerald L. Phillippe Award in recognition of her extraordinary record of volunteer service. She was one of only nine recipients selected for this recognition from over 300,000 GE employees around the world. In addition, in 2012, Ms. Brensinger was nominated and selected for the GE Women in Commercial Program.  Most recently she was honored to be selected for the 21 in 21 – Women in Healthcare Investing by Kayo.

Ms. Brensinger received her BS from York College of Pennsylvania with a Dual Degree in Economics and Finance with a minor in Accounting.

Mr. Chaney is a Founder and Managing Partner of Anagenesis Capital Partners. He is a member of the Investment Committee and is responsible for general management of the firm as well as originating, executing, and managing investments. Mr. Chaney serves on the Boards of various ACP portfolio companies.

Mr. Chaney has over 24 years of private investment experience. Prior to founding Anagenesis, Mr. Chaney was a Managing Director and a member of the US Investment Committee for Intermediate Capital Group, Inc. (ICG). Mr. Chaney joined ICG in 2007 to found the US business and was instrumental in building out the US platform for the firm. At ICG, he was responsible for originating, underwriting, and managing senior debt, mezzanine, and equity investments made on behalf of the firm as well as general management. Mr. Chaney was a board observer of numerous portfolio companies including Cogent HMG, Au Bon Pain, BI Incorporated, Helicon Cable, Hudson Products, Press Ganey, Fort Dearborn, and Convergint Technologies, among others.

Prior to ICG, Mr. Chaney helped found AlpInvest Partners’ mezzanine platform where he was responsible for a number of mezzanine investments aggregating approximately $500 million of invested capital across a variety of industries and was a board observer for multiple companies. Prior to that, he worked at IBJ Whitehall’s Leveraged Finance Group where he worked on leveraged buyout investments and he started his career at The Bank of New York.

Mr. Chaney received his BA from Hamilton College, as well as his MBA from New York University’s Stern School of Business.

Mr. Choi is a Vice President of Anagenesis Capital Partners. He is responsible for sourcing and evaluating investment opportunities, performing due diligence, investment execution and portfolio management. He has over seven years of underwriting, portfolio management and risk management experience.

Prior to joining Anagenesis, Brian was most recently an Assistant Vice President at Capital One Healthcare (formerly the GE Capital Healthcare Financial Services team) and focused exclusively on the healthcare industry. He was responsible for leading the underwriting and due diligence processes on numerous healthcare transactions and overlapped while there with Melanie Brensinger, Scott Clark, and Darren Fuller from our team. Prior to Capital One, Brian served as a risk analyst at GE Capital. There he completed GE’s premier Leadership Program in risk management with roles in the Healthcare Finance unit and GE Capital headquarters.

Brian received a BBA in Finance and Risk Management from the University of Wisconsin – Madison.

Mr. Clark is a Principal of Anagenesis Capital Partners. He is responsible for sourcing and evaluating investment opportunities, performing due diligence, investment structuring and execution, and portfolio management including observation board participation. Mr. Clark also assists in recruiting and training junior investment professionals. Mr. Clark has over 18 years of experience and over 12 of private investment experience.

Prior to joining Anagenesis, Mr. Clark was a Vice President on the Healthcare Leveraged Finance Team at Capital One Bank (formerly the GE Capital Healthcare Financial Services team) where he was responsible for managing multiple teams and underwriting credit investments for healthcare companies. During his 10 + year tenure at GE Capital/Capital One, he assisted in underwriting over $1.7 billion of credit investments and completed GE’s premier Leadership Program in risk management. Prior to joining GE, Mr. Clark was an associate at New Markets Venture Partners and prior to that was the Global IT strategy Manager for ExxonMobil Corporation.

Mr. Clark received his BS in Business Management from Brigham Young University and his MBA from the Robert H. Smith School of Business at the University of Maryland.

Ms. DeBiasi is Chief Financial Officer of Anagenesis Capital Partners. She is responsible for managing financial operations including accounting, tax, treasury, valuations, reporting and planning. She has over nine years of private credit and equity experience.

Prior to joining Anagenesis, Ms. DeBiasi was the Director of Finance at Energy Impact Partners. She was responsible for leading the finance and operational functions for over $1 billion in assets under management. Previously, Ms. DeBiasi worked at LeverPoint Management, a fund administration firm. At LeverPoint she was responsible for the books and records of fifteen private equity, venture capital and credit funds. Her responsibilities included running the operations of the Boston office and reviewing the daily and quarterly transactions and reports for all activities of the funds. Prior to that, Ms. DeBiasi worked at CohnReznick LLP, a public accounting firm where she specialized in private equity and credit fund audits.

Ms. DeBiasi received a BA in Accounting from Assumption College.

Mr. Fuller is a Vice President of Anagenesis Capital Partners. He is responsible for sourcing and evaluating investment opportunities, performing due diligence, investment execution, and portfolio management. Mr. Fuller has over seven years of underwriting, portfolio management and risk management experience.

Prior to joining Anagenesis, Darren was most recently an Assistant Vice President on the Healthcare Leveraged Finance Team at Capital One Healthcare (formerly the GE Capital Healthcare Financial Services team). During his five years at Capital One, he was focused exclusively on the healthcare industry and was responsible for leading the underwriting and due diligence processes on numerous transactions and overlapped while there with Scott Clark and Brian Choi from our team.

Prior to joining Capital One, Darren completed a rotational Management Development Program at M&T Bank. While at M&T and Capital One, Darren passed Level 1-3 CFA exams, receiving CFA designation in ’18. Darren received a BA in Economics from Hamilton College.